Scientific American's departing editor and the politicization of science

I want to be sympathetic to Singal, whose writing always seems to generate shitstorms disproportionate to anything he's actually saying, and whose premise in this piece I tend to agree with (as someone whose politics largely line up with those of the outgoing editor in chief, I've found a lot of what SciAm has posted to be cringe-worthy and destructive).

But what is he on about here?

Or that the normal distribution—a vital and basic statistical concept—is inherently suspect? No, really: Three days after the legendary biologist and author E.O. Wilson died, SciAm published a surreal hit piece about him in which the author lamented "his dangerous ideas on what factors influence human behavior."

(a) The (marked!) editorial is in no way a refutation of the concept of the normal distribution.

(b) It's written by a currently-publishing tenured life sciences professor (though, clearly, not one of the ones Singal would have chosen --- or, to be fair, me, though it's not hard for me to get over that and confirm that she's familiar with basic statistics).

(c) There's absolutely nothing "surreal" about taking Wilson to task for his support of scientific racism; multiple headline stories have been written about it, in particular his relationship with John Philippe Rushton, the discredited late head of the Pioneer Fund.

It's one thing for Singal to have culturally heterodox† views on unsettled trans science and policy issues††, another for him to dip his toes into HBD-ism. Sorry, dude, there's a dark stain on Wilson's career. Trying to sneak that past the reader, as if it was knee-jerk wokeism, sabotages the credibility of your own piece.

Again, the rest of this piece, sure. Maybe he's right. The Jedi thing in particular: major ugh. But I don't want to have to check all of his references, and it appears that one needs to.

† term used advisedly

†† this is what Singal is principally known for

>>It's one thing for Singal to have culturally heterodox† views on unsettled trans science and policy issues††

I think his views are culturally orthodox, outside of liberal-left members of the laptop class.

Red tribe orthodoxy has a lot of disdain for people with trans identities. Blue tribe orthodoxy has maximal dain for those people. But both tribes are willing to promote pseudoscience to achieve their goals. Singal occupies a narrow sliver of the political possibility space where sympathy for those identities can exist at the same time as supporting evidence-based medicine.

Before I started transition I read through the available literature (this would be back in 2010-2015 ish, before it was quite so hot button) and the general consensus wasn't with Singals position then. I don't think skepticism ought to be ruled out or anything, but hormone therapy is better studied than the use of most antidepressants at this point. (although it could still use better study on particular dosage and effects - no one seems to have done anything comprehensive on progestin treatment, for instance, even though it's clearly associated with the rest.)

The Cass report in the UK was pretty clear that there isn't enough evidence to base decisions on https://cass.independent-review.uk/home/publications/final-r...

>>>

While a considerable amount of research has been published in this field, systematic evidence reviews demonstrated the poor quality of the published studies, meaning there is not a reliable evidence base upon which to make clinical decisions, or for children and their families to make informed choices.

The strengths and weaknesses of the evidence base on the care of children and young people are often misrepresented and overstated, both in scientific publications and social debate.

The controversy surrounding the use of medical treatments has taken focus away from what the individualised care and treatment is intended to achieve for individuals seeking support from NHS gender services.

The rationale for early puberty suppression remains unclear, with weak evidence regarding the impact on gender dysphoria, mental or psychosocial health. The effect on cognitive and psychosexual development remains unknown.

The use of masculinising / feminising hormones in those under the age of 18 also presents many unknowns, despite their longstanding use in the adult transgender population. The lack of long-term follow-up data on those commencing treatment at an earlier age means we have inadequate information about the range of outcomes for this group.

The report basically said that there wasn't a lot of evidence that the treatments in question make people happy in the long run, which is an unusual standard to apply. Usually we look for evidence that medical treatments achieve their medical goals, and leave judgments about what will or won't make someone happy to doctors or patients. (For example, it's questionable whether certain cancer treatments that extend life by only a few months will be a net benefit for patients, but we generally let patients and doctors decide for themselves whether or not to go ahead with them.)

Given that the treatments are meant to address gender dysphoria which is unhappiness caused by a sense of misalignment with one's sexual characteristics I struggle to think of a better measure of success than long-term happiness.